A treatment to prevent heart block in babies by blocking IgG recycling during pregnancy
Official title: Atrioventricular Block Elimination by Rozanolixizumab Treatment
Funded at New York University School of Medicine · NIH-11417266 · Data updated 2026-11-12
A new approach aims to protect unborn babies from heart damage by using Rozanolixizumab to lower harmful antibodies that can cross from mother to fetus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2025 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $717,221 |
| NIH project number | 5R01AR087521-02 |
| Project ID | NIH-11417266 on NIH RePORTER |
Who could benefit from this research
✓Could help
Pregnant individuals known to carry autoantibodies associated with cardiac-NL and at risk for fetal heart block.
✕Less likely to help
Pregnancies without high-risk autoantibodies or where fetal heart block risk is low may see no benefit.
What this research studies
This study focuses on pregnant people at risk for having babies with cardiac neonatal lupus due to autoantibodies. By inhibiting the FcRn receptor, the project seeks to reduce pathogenic IgG levels that reach the fetus, potentially preventing irreversible heart block. The research builds on prior findings of autoantibodies linked to heart damage and uses maternal treatment to shield fetal heart development. Participants would be monitored for safety and fetal outcomes through pregnancy and after birth.
Why it matters
Potential benefit: If successful, the approach could reduce the risk of fetal heart block and improve long-term heart health for affected children.
How similar studies have gone: Earlier STOP BLOQ studies and related work support the concept of preventing antibody-mediated fetal disease, with evidence of autoantibody involvement in cardiac-NL.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Buyon, Jill P — New York University School of Medicine
- Study coordinator: Buyon, Jill P
Related research
Other NIH-funded projects on the same topics.
-
Preventing fetal heart block through early monitoring and treatment
This study is looking at how to help prevent serious heart problems in unborn babies by having expectant moms check their baby's heart rate every day, so they can catch any issues early and get the right treatment in time.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
Left bundle area pacing with Closed Loop Stimulation in dual‑chamber pacemakers
This study tests whether a dual‑chamber pacemaker using left bundle area pacing and Closed Loop Stimulation can reduce device‑detected atrial fibrillation over 24 months in patients with sinus node disease and AV conduction issues.
-
Remote ECG monitoring after TAVI
This compares continuous 30-day remote ECG monitoring to standard short-term monitoring for adults after TAVI to see if it detects rhythm problems earlier.
-
Conduction system pacing vs. traditional pacing in adults with atrioventricular block
This study tests whether stimulating the heart’s conduction system can reduce heart failure events for adults needing pacemakers due to AV block.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.